Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    -3.00 (-0.57%)
Bid:
524.00
Ask:
526.00
Spread: 2.00 (0.382%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Trading Statement

7 Nov 2018 13:00

RNS Number : 6607G
Galliford Try PLC
07 November 2018
 

7 November 2018

 

Galliford Try plc

 

Update on Aberdeen Western Peripheral Route and Current Trading

Galliford Try plc ("Galliford Try" or the "Group"), the housebuilding, regeneration and construction group today issues an update on the Aberdeen Western Peripheral Route ("AWPR") contract and Group trading. This statement covers the period 1 July 2018 to 7 November 2018.

 

On AWPR, the completion date for the final section, including the bridge over the River Don, is now expected to be in December owing to increased complexity and weather delays in implementing repairs to the bridge. As a result of higher than anticipated direct costs, and the further delay to completion, our estimate of the final costs to complete the contract has increased by approximately £20m. The final impact on the Galliford Try's financial results will be determined more importantly by the result of the Group's significant claim, in respect of which the Board continues to pursue constructive discussions with the client.

 

The underlying Construction business continues to trade in line with expectations.

 

Linden Homes continues to make good progress against its strategic targets. Sales rates are lower than levels achieved in FY 2018, but prices and margins remain in line with expectations and the business expects to achieve its targets for the full year.

 

Partnerships & Regeneration is trading strongly in both mixed-tenure and contracting, with continuing strong demand across all regions, backed by resolute political support for this sector.

 

The Group expects to report a FY 2019 pre-exceptional profit before tax in line with previous guidance. Average net debt for FY 2019 is expected to remain in the previously guided range of £170m to £190m before any recoveries in relation to the AWPR contract.

 

This announcement contains inside information.

 

For further enquiries please contact:

 

Galliford Try

Peter Truscott, Chief Executive 01895 855001

Graham Prothero, Finance Director

 

Tulchan Communications

James Macey White 020 7353 4200

Martin Pengelley

Elizabeth Snow

 

Notice of results

 

Galliford Try will hold its Annual General Meeting at 10:30 am on Friday 9 November 2018 at the offices of CMS Cameron McKenna Nabarro Olswang LLP, Cannon Place, 78 Cannon Street, London, EC4N 6AF.

 

Galliford Try expects to announce its interim results for the six months to 31 December 2018 on 13 February 2019.

 

The person responsible for making this announcement on behalf of Galliford Try is Kevin Corbett, General Counsel & Company Secretary.

 

Notes to editors

 

Galliford Try is listed on the London Stock Exchange and is a member of the FTSE 250. Housebuilding - through our Linden Homes business - develops private and affordable homes in prime locations. Galliford Try Partnerships - our regeneration business - delivers mixed-tenure solutions working with housing association, local authority and private sector partners. Operating as Galliford Try and Morrison Construction, our Construction business carries out building and infrastructure projects with clients in the public, private and regulated sectors. At the end of the last financial year to 30 June 2018, the Group generated revenue of £3.1 billion.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFSFLFLDIIT
Date   Source Headline
6th Jul 20233:30 pmRNSHolding(s) in Company
6th Jul 20237:00 amRNSTransaction in Own Shares
4th Jul 20237:00 amRNSTransaction in Own Shares
3rd Jul 20232:32 pmRNSTotal Voting Rights
21st Jun 20237:00 amRNSTransaction in Own Shares
9th Jun 20237:00 amRNSTransaction in Own Shares
8th Jun 20237:00 amRNSSettlement Agreed and Special Dividend
7th Jun 20237:00 amRNSTransaction in Own Shares
6th Jun 20237:00 amRNSTransaction in Own Shares
1st Jun 202311:00 amRNSConfirmation of Directorate Change
1st Jun 202310:15 amRNSTotal Voting Rights
1st Jun 20237:00 amRNSTransaction in Own Shares
31st May 20237:00 amRNSTransaction in Own Shares
18th May 20233:30 pmRNSHolding(s) in Company
18th May 20237:00 amRNSTransaction in Own Shares
17th May 20233:00 pmRNSAppointment of Non Executive Director
17th May 20237:00 amRNSTransaction in Own Shares
11th May 20237:10 amRNSContract
10th May 20237:00 amRNSTransaction in Own Shares
3rd May 20237:00 amRNSTransaction in Own Shares
2nd May 202311:00 amRNSTotal Voting Rights
2nd May 20237:10 amRNSContract
2nd May 20237:00 amRNSTransaction in Own Shares
27th Apr 20237:00 amRNSTransaction in Own Shares
26th Apr 20237:00 amRNSTransaction in Own Shares
25th Apr 20232:00 pmRNSDirector/PDMR Shareholding
13th Apr 20237:10 amRNSContract
11th Apr 20237:00 amRNSTransaction in Own Shares
6th Apr 20237:00 amRNSTransaction in Own Shares
5th Apr 20237:00 amRNSTransaction in Own Shares
4th Apr 20237:00 amRNSTransaction in Own Shares
3rd Apr 202310:00 amRNSTotal Voting Rights
31st Mar 20233:00 pmRNSConfirmation of Director Change
30th Mar 20237:00 amRNSTransaction in Own Shares
29th Mar 20237:05 amRNSContract
29th Mar 20237:00 amRNSTransaction in Own Shares
27th Mar 20237:00 amRNSTransaction in Own Shares
24th Mar 20239:37 amRNSCorrection: Transaction in Own Shares
24th Mar 20237:00 amRNSContract
23rd Mar 20237:00 amRNSContract
22nd Mar 20237:00 amRNSTransaction in Own Shares
15th Mar 202310:30 amRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSContract
8th Mar 20237:10 amRNSTransaction in Own Shares
8th Mar 20237:00 amRNSHalf-year Report
7th Mar 20237:00 amRNSTransaction in Own Shares
6th Mar 20237:00 amRNSContract
1st Mar 20239:35 amRNSTotal Voting Rights
27th Feb 20234:00 pmRNSHolding(s) in Company
24th Feb 202310:42 amRNSBlock Listing Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.